CLDF Title
Home | Contact Us | Bookmark
 
 
About CLDF Centers of Educational Expertise
 
Back Substance Use Disorder Centers of Educational Expertise  
Banner
 
Lawrence Brown
Dr. Lawrence Brown is the current Chief Executive Officer of START Treatment & Recovery Centers. In his role, Dr. Brown is responsible for all aspects of health care services, oversight of health care professionals, and the conduct of behavioral and bio-medical research.  More
 
  CME and Independent Education  
 
   
 
  Physician Resources 
 
 
  My Publications More  
 
  Alcohol education provided to opioid treatment program patients: results of a nationwide survey.
 
  Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.
 
  Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
 
  Electronic medical record system at an opioid agonist treatment programme: study design, pre-implementation results and post-implementation trends.
 
 
 
  Institution Information
START Treatment and Recovery Centers offer holistic care when treating those with an opioid addiction and co-occurring mental illness to transition patients toward healthy and productive lives. The seven community-based treatment programs use individual and group counseling with medical and behavioral health professionals to treat patients, and some clinics offer short-term, outpatient detoxification and a drug-free chemical dependency program for other non-opiate addictions.
More
 
 
Institution Link  
 
     
  Journal Abstracts  
  Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success  
     
  New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care  
     
  Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study  
     
  New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases  
     
  L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathyin people with cirrhosis  
     
  Late Development of Hepatocellular Carcinoma After Viral Clearance in Chronic Hepatitis C Patients: A Need for Continual Surveillance  
     
  View All Articles  
     
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.